$CRIS News Insiders are bullish on these stocks 11:14

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CRIS News

Insiders are bullish on these stocks 11:14 a.m. Dec. 11, 2012 - Insider Monkey
FDA approves Roche-Curis drug to treat skin cancer 2:10 p.m. Jan. 30, 2012 - MarketWatch.com
Drug stocks climb; Siga sinks on contract woes 3:53 p.m. June 14, 2011 - Val Brickates Kennedy
Analyst downgrades weigh on drug stocks 3:47 p.m. April 29, 2011 - Val Brickates Kennedy
Analyst downgrades weigh on drug stocks 10:01 a.m. April 29, 2011 - Val Brickates Kennedy
Wednesday’s biggest advancers and decliners 4:35 p.m. April 6, 2011 - Kate Gibson
Optimer, Curis, Orchid in drug-sector spotlight 4:33 p.m. April 6, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 3:34 p.m. March 21, 2011 - Kate Gibson
Curis leads advance for drug stocks 2:38 p.m. March 21, 2011 - Val Brickates Kennedy
Curis soars on skin cancer trial 9:02 a.m. March 21, 2011 - Val Brickates Kennedy
The best biotech stocks to own now 1:01 a.m. Jan. 13, 2011 - Michael Shulman
Monday's biggest gaining and declining stocks 6:16 p.m. Aug. 9, 2010 - MarketWatch
Wednesday's biggest gaining and declining stocks 4:54 p.m. June 16, 2010 - MarketWatch
Friday's biggest gaining and declining stocks 3:53 p.m. Jan. 22, 2010 - MarketWatch
Drug stocks mixed; Curis and Achillion tumble 12:17 p.m. Jan. 22, 2010 - Val Brickates Kennedy
BEFORE THE BELL -2: US HOT STOCKS TO WATCH 8:54 a.m. Sept. 3, 2009 - Dow Jones
Schering-Plough, Merck slide on Vytorin woes 1:46 p.m. Dec. 12, 2007 - Val Brickates Kennedy
Drugs stocks post modest losses 10:03 a.m. Sept. 25, 2007 - William Spain
Drug, biotech stocks trade broadly lower; Dendreon plunges 2:22 p.m. May 9, 2007 - Carolyn Pritchard
Drug stocks mixed, Dynavax rockets on allergy study 4:40 p.m. Oct. 5, 2006 - Val Brickates Kennedy


Exelixis (EXEL) Jumps: Stock Adds 11.4% in Session - Tale of the Tape 9:39 a.m. July 25, 2014 - Zacks.com
Celsion (CLSN) in Focus: Stock Adds 5.3% in Session - Tale of the Tape 8:51 a.m. July 25, 2014 - Zacks.com
Illumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance - Analyst Blog 12:00 p.m. July 24, 2014 - Zacks.com
Amicus Therapeutics (FOLD) Jumps: Stock Rises 7.1% - Tale of the Tape 9:39 a.m. July 24, 2014 - Zacks.com
Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher - Tale of the Tape 9:11 a.m. July 24, 2014 - Zacks.com
Biogen Idec (BIIB) Soars: Stock Adds 11.2% in Session - Tale of the Tape 8:51 a.m. July 24, 2014 - Zacks.com
Ultragenyx (RARE) Jumps: Stock Moves 7.8% Higher - Tale of the Tape 9:25 a.m. July 21, 2014 - Zacks.com
CVS Caremark Forms Clinical Alliances to Boost Health Care - Analyst Blog 3:20 p.m. July 17, 2014 - Zacks.com
Ligand Pharmaceuticals (LGND) in Focus: Stock Falls 6.7% - Tale of the Tape 8:31 a.m. July 17, 2014 - Zacks.com
CVS Caremark to Expand with Navarro Discount Pharmacy Buyout - Analyst Blog 3:10 p.m. July 15, 2014 - Zacks.com
Bruker's Inspire Mapping System Fails to Inspire Share Prices - Analyst Blog 3:20 p.m. July 14, 2014 - Zacks.com
Sarepta Therapeutics Slumps: SRPT Tanks 12.9% in Session - Tale of the Tape 8:42 a.m. July 11, 2014 - Zacks.com
Should You Get Rid of Kamada (KMDA) Now? - Tale of the Tape 8:34 a.m. July 11, 2014 - Zacks.com
Will Curis (CRIS) Crush Estimates at Its Next Earnings Report? - Tale of the Tape 8:43 a.m. July 10, 2014 - Zacks.com
China Biologic Products, Inc. (CBPO) Jumps: Stock Surges 10.8% - Tale of the Tape 9:11 a.m. July 9, 2014 - Zacks.com
Ultragenyx Pharmaceutical Slumps: RARE Plunges 11.7% in Session - Tale of the Tape 8:33 a.m. July 9, 2014 - Zacks.com
Curis (CRIS) Soars: Stock Adds 11.4% in Session - Tale of the Tape 8:51 a.m. July 1, 2014 - Zacks.com
Basket Of Biotech Bargains To Buy And Hold 4:23 p.m. June 30, 2014 - Seeking Alpha
Curis and Roche File Label Expansion for Erivedge - Analyst Blog 5:44 p.m. June 25, 2014 - Zacks.com
$2 Or Less: 2 Speculative Biotechs Moving Up 4:52 p.m. June 23, 2014 - Seeking Alpha


Health Care Sector Stocks Technical Review: Valeant Pharma, Teva Pharma Industries, Novo Nordisk, Curis, and Amarin 8:10 a.m. July 17, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 6:20 a.m. July 2, 2014 - PR Newswire - PRF
Curis Announces Investigational New Drug Application Filing by Roche to Initiate a Phase 2 Study of Erivedge(R) (vismodegib) in Idiopathic Pulmonary Fibrosis 7:01 a.m. June 23, 2014 - GlobeNewswire
Curis to Present at the JMP Securities Healthcare Conference 7:01 a.m. June 18, 2014 - GlobeNewswire
Technical Snapshot on Biotech Stocks -- Research on Aegerion Pharma, Biogen Idec, Lexicon Pharma, and Curis 8:30 a.m. June 5, 2014 - PR Newswire - PRF
Curis Announces Executive Management Transition 7:00 a.m. June 3, 2014 - GlobeNewswire
Curis to Present at the Jefferies 2014 Global Healthcare Conference 7:01 a.m. May 29, 2014 - GlobeNewswire
Curis Announces Abstracts for Its Partnered Programs, Erivedge(R) and Debio 0932 to be Presented at the 2014 ASCO Annual Meeting 7:01 a.m. May 23, 2014 - GlobeNewswire
Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014 11:35 a.m. May 21, 2014 - PR Newswire - PRF
Curis Reports First Quarter 2014 Financial Results 7:02 a.m. May 8, 2014 - GlobeNewswire
Curis to Release First Quarter 2014 Financial Results and Hold Conference Call on May 8, 2014 7:02 a.m. May 1, 2014 - GlobeNewswire
Curis Announces U.S. Patent Issuance Covering CUDC-907 Composition-of-Matter 7:02 a.m. April 30, 2014 - GlobeNewswire
Curis to Present at the Deutsche Bank 39th Annual Health Care Conference 6:46 a.m. April 30, 2014 - GlobeNewswire
Curis and Debiopharm Group Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014 3:30 a.m. April 8, 2014 - PR Newswire - PRF
Curis Reports CUDC-907 and CUDC-427 Data at AACR Annual Meeting 2014 4:06 p.m. April 7, 2014 - GlobeNewswire
Curis and Debiopharm Group(TM) Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014 4:03 p.m. April 7, 2014 - GlobeNewswire
Curis to Present at the 13th Annual Needham Healthcare Conference 7:20 a.m. April 2, 2014 - GlobeNewswire
Curis Announces Removal of FDA Partial Clinical Hold on CUDC-427 7:01 a.m. March 31, 2014 - GlobeNewswire
Curis Announces Presentation of Data for CUDC-907, CUDC-427 and Debio 0932 at AACR Annual Meeting 6:30 a.m. March 31, 2014 - GlobeNewswire
Curis to Present at the 26th Annual ROTH Conference 8:11 a.m. March 4, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyosung Targets U.S. AI Power Market with Advanced SST

Updated Category News Views 3

Hyosung's Game-Changing Move in the AI Power Sector Guess what? The AI era's heating up, and it's dragging the power sector along for a wild ride. Hyosung Chairman Hyun-Joon Cho peered into that future and decided it's all-in time for the U.S. power market. With AI and data centers cranking up power demands like never before, those rickety old wires need an upgrade fast....

Continue Reading
CalExitNow Fights Federal Interference in CA Elections

Updated Category News Views 2

California's Election Integrity: A Ticking Time Bomb Strap in for a bumpy ride, folks—California might soon find its electoral process caught in a Washington whirlwind. CalExitNow, the group advocating for California's independence, is sounding alarms about looming federal interventions that could shake the state's democratic foundations. The Federal Storm Rolling In...

Continue Reading
Ping An Climbs Sustainability Ladder, Scores A+ Rating

Updated Category News Views 5

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

Continue Reading
GBC 2026 Wraps Up: Korea Eyes Bio Industry Leadership

Updated Category News Views 3

GBC 2026: Korea's Giant Leap in Bio Innovation Well, there wasn't a dull moment at the 'Global Bio Conference 2026' in Seoul. Picture a melting pot where 5,600 participants from 19 countries converged to chat about the latest and greatest in biopharma innovation and regulatory strategies. That's not a setup you see every day, mind you. This event packed the room with...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 9

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Interventional Ophthalmology: Early Eye Care Strategies Evolve

Updated Category News Views 1

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Continue Reading
Kean-NJCU Merger: A Strategic Educational Move

Updated Category News Views 3

The clock's ticked for Kean University and New Jersey City University, landing them into a fusion that's set tongues wagging across the education sector. This ain't just another day at the park—it’s a significant shift in the academic landscape that deserves a closer, sharper look. Behind the Curtains of Strategic Planning So, who’s behind the wheel charting this...

Continue Reading
AXIS-Y: Global Expansion Fueled by KRW 430B Valuation

Updated Category News Views 4

Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...

Continue Reading
Snack Bars Market to Hit $32.66B by 2031: Growth and Challenges

Updated Category News Views 2

Snack Bars Navigate a Transforming Market There's a headwind in the snack bars market as it looks to lift off from $21.94 billion and land at $32.66 billion by 2031. That's a solid climb at an 8.28% CAGR. What's fueling this leap? A desire for convenient, portable nutrition that's squeezing into every nook of modern life—from the gym to the car, to your kid's lunchbox....

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 1

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading

Top 5 Most Recently Viewed Articles

ICON PLC Faces Class Action Lawsuit Amid Significant Losses

Updated Category News Views 287

ICON PLC Faces Class Action Lawsuit Amid Significant Losses The law firm of Robbins Geller Rudman & Dowd LLP has officially announced that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares have the opportunity to lead a class action lawsuit. This action is for investors who experienced significant financial losses between July 27, 2023, and October 23, 2024. The...

Continue Reading
Essex Property Trust EVP's Significant Stock Transaction Insights

Updated Category News Views 63

Recent Executive Stock Transactions In a significant move, Anne Morrison, serving as the Executive Vice President, Chief Administrative Officer, and General Counsel at Essex Property Trust, Inc. (NYSE: ESS), sold shares worth over $800,000. Specifically, she sold 2,571 shares at an average price of $314.79, totaling about $809,325. Investors closely watch insider trading...

Continue Reading
TDb Split Corp. Announces Key Financial Updates for Investors

Updated Category News Views 132

TDb Split Corp. Financial Overview TDb Split Corp. has recently published its annual financial statements for the fiscal year concluding on November 30, 2024. These documents detail the company's performance and are accessible for stakeholders to review. Annual Financial Performance Highlights The management report offers insights into the company's fund performance,...

Continue Reading
Baltic Horizon Fund Sees Positive NAV Growth in May 2025

Updated Category News Views 127

Growth of Baltic Horizon Fund's NAV in May 2025 The Baltic Horizon Fund reported an increase in its net asset value (NAV) per unit, which rose to EUR 0.6757 at the close of May 2025. This figure represents a slight gain from the NAV of EUR 0.6740 recorded at the end of April 2025. The fund's overall net asset value reached EUR 97.0 million, up from EUR 96.8 million in the...

Continue Reading
Fractyl Health's Insights on Q2 2025 Financial Performance

Updated Category News Views 135

Fractyl Health to Report Second Quarter 2025 Financial Results Fractyl Health, Inc. (Nasdaq: GUTS), a leader in metabolic therapeutics, is set to release its financial results for the second quarter of 2025. The report will be available on August 12, 2025, at 4:30 p.m. ET. This pivotal moment is crucial for stakeholders as the company shares insights into its financial...

Continue Reading